Evaluation of synthetic mRNA with selected UTR sequences and alternative poly(A) tail, in vitro and in vivo
Open accessAbstract
Messenger RNA (mRNA) has emerged as an attractive new technology of drugs. The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation. Untranslated regions (UTRs) and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics. Intending to improve the therapeutic potential of synthetic mRNA, we evaluated various UTRs and tail designs, using Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine sequences as a reference. First, we screened six 5′ UTRs (cap-dependent/-independent), evaluated nine 5′ UTR-3′ UTR combinations, and a novel heterologous A/G tail in cell models, and in vivo using luciferase as a reporter gene. Then, to decipher the translation mechanism of selected UTRs, we correlated mRNA expression with ribosome load, mRNA half-life, mRNA immunogenicity, and UTR structures. Our results showed that the heterologous tail we introduced is as potent as the Pfizer-BioNTech tail and confirmed the high potency of the human α-globin 5′ UTR. They also revealed the potential of the VP6 and SOD 3′ UTRs. We validated our results using mRNA encoding the SARS-CoV-2 spike protein formulated as lipid nanoparticles (LNPs) for mouse immunization. Overall, the selected 3′ UTRs and heterologous A/G tail have great potential as new elements for therapeutic mRNA design.
Verified 2026-11-05 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This study systematically evaluated synthetic mRNA designs, including a novel heterologous A/G poly(A) tail and various 5′/3′ UTR combinations, using reporter and SARS-CoV-2 spike mRNAs in cell models and mice. The A/G tail was as potent as the Pfizer-BioNTech A30L70 tail and more stable in bacteria, while VP6 and SOD 3′ UTRs showed potential as alternatives to AES-mtRNR1.
Key findings
- The novel A/G tail was highly stable in *E. coli* after 10 passages: 100% of clones retained tail integrity, versus 90% for A30L70 and 10% for A120. In HeLa cells, A/G mRNA produced 25% less total protein than A30L70 mRNA, but in mice it produced only 10% less total protein, indicating comparable potency.
- Cap-independent IRES 5′ UTRs (VCIP, CrPV, EMCV) translated at less than 20% of the human α-globin (hAg) 5′ UTR level across HeLa, C2C12, and DC2.4 cells. hAg, UTR3, and UTR4 were selected as the top cap-dependent 5′ UTRs.
- Among 5′ UTR–3′ UTR combinations, hAg-VP6 and hAg-SOD produced significantly more protein than the benchmark hAg-AES in C2C12 cells; UTR4-SOD produced less than 50% of benchmark protein in AB1079 human myoblasts. In polysome profiling, UTR3-SOD and UTR4-SOD associated with polysomes at less than 25%.
- In vivo, UTR3-AES produced 10-fold less protein than hAg-AES with Fluc mRNA. In SARS-CoV-2 spike mRNA vaccination, VP6 and SOD 3′ UTRs produced more spike protein than AES in HeLa and AB1079 cells, improving protein yields by 40% compared to benchmark in human muscle cells, but mouse IgG and neutralizing antibody responses were comparable across groups.
Methods
- The study compared poly(A) tail designs (A120, A30L70, and a novel A/G tail), seven 5′ UTRs, and nine 5′ UTR–3′ UTR combinations using NanoLuc, firefly luciferase, or SARS-CoV-2 spike reporter mRNAs.
- Experiments included bacterial passage stability assays, synchrotron radiation circular dichroism (SRCD), transfection into HeLa, C2C12, DC2.4, AB1079, and monocyte-derived dendritic cells, RT-qPCR, FISH-Flow, polysome profiling, luciferase assays, and spike ELISA.
- In vivo work used BALB/c mice with LNP-formulated mRNA for intramuscular luciferase expression (1 μg mRNA; n = 3–7 per group) and spike immunization (5 μg mRNA; n = 5 per group, two doses), with bioluminescence imaging, anti-spike IgG ELISA, and neutralizing antibody assays; statistical analysis used nested one-way ANOVA or Kruskal-Wallis tests.
Limitations
- The paper states that the A/G tail can be further improved by optimizing the percentage of G residues and overall tail length, and that future studies will evaluate poly(A)-binding protein (PABP) binding.
- The paper notes that predicting optimal 5′/3′ UTR combinations is challenging due to tissue- and cell-type dependencies and RNA folding that can be affected by the coding sequence.
- Evident from the text: in vivo experiments were limited (one experiment with small group sizes; UTR in vivo n = 3–7, immunization n = 5), and no statistically significant differences in IgG or neutralizing antibodies were observed among the three 3′ UTRs after boost, nor for the A/G tail versus A30L70 IgG comparison.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
23 of 36 cited sources checked · 13 supported · 1 flagged · accuracy not yet measured
- Premisecitation
UTRs and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics.
“Untranslated regions (UTRs) and the poly(A) tail play a crucial role in regulating mRNA intracellular kinetics.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [4] Kang, 2023, Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics, Adv. Drug Deliv. Rev. source
- Premisecitation
The presence of the poly(A) tail on the plasmid template for mRNA production is not stable and prone to shortening in bacteria during plasmid DNA amplification.
“However, the presence of the poly(A) tail on the plasmid template for mRNA production is not stable and prone to shortening in bacteria during plasmid DNA amplification.17”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] Grier, 2016, pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences, Mol. Ther. Nucleic Acids source
The Results section (‘Homopolymeric poly(A) tracts 175 bp or longer are extremely unstable in circular plasmids’; page not provided) reports shortening after bacterial transformation of circular plasmids carrying long poly(A) tracts. The claim omits important limits: 70-bp tracts remained stable, and another Results section reports that poly(A) tracts in the linear pEVL plasmid were highly stable during extended propagation, except that the ~500-bp tract tended to shorten. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
The translation initiation efficiency of mRNA is affected by the sequence and structure of the 5′ UTR region.
“The translation initiation efficiency of mRNA is affected by the sequence and structure of the 5′ UTR region.5”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [5] Hinnebusch, 2016, Translational control by 5′-untranslated regions of eukaryotic mRNAs, Science source
- Premisecitation
The synthetic 5′ UTR UTR4 allows strong expression of mRNA in cells and Zebrafish.
“the synthetic 5′ UTR UTR4 allowing strong expression of mRNA in cells and Zebrafish27”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [27] Linares-Fernández, 2021, Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA, Mol. Ther. Nucleic Acids source
- Premisecitation
Incorporation of non-A nucleotides, particularly guanosine, can interfere with the deadenylation process, thereby enhancing mRNA stability.
“Previous studies have shown that the incorporation of non-A nucleotides, particularly guanosine, can interfere with the deadenylation process, thereby enhancing mRNA stability.41”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [41] Lee, 2024, Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution, Nat. Struct. Mol. Biol. source
- Premisecitation
Shortening of the poly(A) sequence directly affects the translation efficiency of the mRNA.
“This instability, characterized by shortening of the poly(A) sequence, directly affects the translation efficiency of the mRNA.17”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] Grier, 2016, pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences, Mol. Ther. Nucleic Acids source
- Interpretationcitation
The finding that cap-independent 5′ UTRs have poor translation rate is consistent with previous studies showing IRES are more efficient under stress conditions.
“Our results demonstrated that cap-independent 5′ UTRs exhibited a poor translation rate across three different cell lines compared to cap-dependent 5′ UTRs, which is consistent with previous studies showing that IRES are more efficient under stress conditions.42,43”
Quote in the paperNot a substantial claim1 of 2 sources checked - Premisecitation
The synthetic 5′ UTR neoUTR3 shows enhanced protein production.
“the synthetic 5′ UTR neoUTR3 showing enhanced protein production (UTR3).9”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [9] Cao, 2021, High-throughput 5’ UTR engineering for enhanced protein production in non-viral gene therapies, Nat. Commun. source
- Findingown data
SRCD analysis showed that UTR3-AES Fluc mRNA had a different profile compared to UTR3-VP6 Fluc mRNA.
“Additionally, SRCD analysis showed that UTR3-AES Fluc mRNA had a different profile compared to UTR3-VP6 Fluc mRNA”
Quote in the paperSubstantial claim - Findingown data
In BALB/c mice two weeks after the first injection, mRNA with AES-mtRNR1 or VP6 3′ UTRs induced higher production of IgG anti-RBD spike protein compared to SOD 3′ UTR mRNA.
“Two weeks after the first injection, mRNA with AES-mtRNR1 or VP6 3′ UTRs induced higher production of IgG anti-RBD spike protein compared to the SOD 3′ UTR mRNA (Figure 7F).”
Quote in the paperSubstantial claim - Findingown data
In HeLa cells, A30L70-mRNA showed progressively higher bioluminescence than A/G-mRNA from 24 to 96 h, reaching up to 2-fold greater at 96 h.
“However, from 24 to 96 h, A30L70-mRNA exhibited a progressively higher bioluminescence signal, reaching up to 2-fold greater intensity at 96 h (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
In HeLa and AB1079 cells, VP6 and MnSOD 3′ UTRs produced more spike protein than the AES-mtRNR1 3′ UTR.
“The VP6 and MnSOD 3′ UTRs produced more spike protein than the AES-mtRNR1 3′ UTR (Figures 7B and 7C)”
Quote in the paperSubstantial claim - Findingown data
One week after the second injection (boost), no significant differences in IgG production were observed among the three 3′ UTRs.
“Interestingly, 1 week after the second injection (boost), no significant differences in IgG production were observed among the three 3′ UTRs (Figure 7G).”
Quote in the paperNot a substantial claim - Findingown data
FISH-Flow showed comparable Nluc mRNA levels at 2 and 24 h after transfection for hAg-AES, hAg-VP6, and hAg-SOD mRNAs.
“FISH-Flow results showed comparable Nluc mRNA levels at 2 and 24 h after transfection for hAg-AES, hAg-VP6, and hAg-SOD mRNAs (Figure S5A).”
Quote in the paperSubstantial claim - Findingown data
Translation of all constructs except CrPV was inhibited by 90% using the eIF4G initiation pathway inhibitor 4EGI-1.
“Moreover, the translation of all constructs except CrPV was inhibited by 90% using the canonical eIF4G initiation pathway inhibitor (4EGI-1).”
Quote in the paperSubstantial claim - Findingown data
A30L70-tailed mRNA had a higher melting temperature (76.6 ± 1.3°C) than A120-tailed (69.4 ± 1.1°C) and A/G-tailed (69.8 ± 1.4°C) mRNA.
“A30L70-tailed mRNA had a higher Tm (76.6 ± 1.3°C) compared to A120 (69.4°C ± 1.1°C) and A/G-tailed mRNA (69.8°C ± 1.4°C).”
Quote in the paperSubstantial claim - Findingown data
In cell-free translation assays, the nine mRNAs were similarly translated.
“Furthermore, in cell-free translation assays, the nine mRNAs were similarly translated (Figure S3A)”
Quote in the paperSubstantial claim - Findingown data
mRNAs with CleanCap AG yielded two times more protein than mRNAs with the ARCA cap analog.
“However, as expected, mRNAs with CleanCap AG yielded two times more protein than mRNAs with the ARCA cap analog (Figure S4).”
Quote in the paperNot a substantial claim - Findingown data
In HeLa cells, A/G-mRNA produced 25% less total protein over time (AUC) than A30L70-mRNA.
“The total amount of protein produced was quantified using area under the curve (AUC) analysis, which showed that A/G-mRNA produced 25% less protein overall compared to A30L70-mRNA (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
In HeLa cells, transfection with Fluc mRNA containing UTR3-AES resulted in lower protein production than the benchmark hAg-AES.
“In line with the in vivo findings, the transfection of HeLa cells with Fluc mRNA containing UTR3-AES resulted in lower protein production than the benchmark mRNA (hAg-AES) (Figure S6).”
Quote in the paperSubstantial claim - Findingown data
In BALB/c mice after intramuscular injection, A/G-tailed and A30L70-tailed Fluc mRNAs exhibited comparable bioluminescence over 72 h.
“As illustrated in Figure 2C, mRNAs with both tails exhibited comparable bioluminescence expression over the 72-h period post-administration.”
Quote in the paperSubstantial claim - Findingown data
mRNAs containing IRES 5′ UTRs (VCIP, CrPV, EMCV) translated less than 20% of the luciferase expression achieved with cap-dependent human alpha-globin 5′ UTR across HeLa, C2C12, and DC2.4 cells.
“The results showed that the translation of mRNAs containing IRES 5′ UTRs derived from mammalian or viral sources (VCIP, CrPV, EMCV) was less than 20% of the luciferase expression achieved with the cap-dependent human alpha-globin 5′ UTR across the three cell lines tested (Figures 3B–3D).”
Quote in the paperSubstantial claim - Findingown data
The melting temperatures of the 3′ UTRs were equivalent: 76.6 ± 1.4°C for AES-mtRNR1, 76.4 ± 0.7°C for VP6, and 69.7 ± 5.7°C for SOD.
“Tm of the 3′ UTRs were equivalent: 76.6°C ± 1.4°C for AES-mtRNR1, 76.4°C ± 0.7°C for VP6, and 69.7°C ± 5.7°C for SOD.”
Quote in the paperSubstantial claim - Findingown data
mRNAs containing hAg, UTR3, or UTR4 5′ UTRs had comparably high Nluc expression across HeLa, C2C12, and DC2.4 cells.
“We also observed comparably high Nluc expression levels with mRNAs containing hAg, UTR3, or UTR4 5′ UTRs across all three cell lines tested.”
Quote in the paperSubstantial claim - Findingown data
Modified (m1Ψ) Spike mRNA yielded 10 times more protein than unmodified Spike mRNA in HeLa cells.
“The results showed that the modified mRNA yielded 10 times more than the unmodified mRNA (Figure S5B).”
Quote in the paperNot a substantial claim - Findingown data
In C2C12 cells, hAg-VP6 and hAg-SOD combinations produced significantly higher protein than the benchmark hAg-AES.
“Noteworthy, in C2C12 cells, hAg-VP6 and hAg-SOD combinations produced significantly a higher amount of protein than the benchmark (Figure 4D).”
Quote in the paperSubstantial claim - Findingown data
UTR4 had a drastically lower melting temperature (59.6 ± 1.6°C) compared to hAg (79.2 ± 0.9°C) and UTR3 (76.3 ± 0.9°C).
“However, UTR4 had a drastically lower Tm (59.6°C ± 1.6°C) compared to hAg (79.2°C ± 0.9°C) and UTR3 (76.3°C ± 0.9°C).”
Quote in the paperNot a substantial claim - Findingown data
When paired with 3′ UTR SOD, UTR4 yielded 2-fold less protein compared to the reference.
“Despite the 5′ UTR UTR4 being identified in high ribosome load analysis,27 when paired with 3′ UTR SOD, it yielded 2-fold less protein compared to the reference (Figure 4).”
Quote in the paperSubstantial claim - Findingown data
The use of m1Ψ led to decreased dsRNA levels.
“Interestingly, the use of m1Ψ led to decreased dsRNA levels, as did the use of CleanCap AG compared to ARCA cap analog (Table S3).”
Quote in the paperSubstantial claim- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
- Findingreasoning
CleanCap AG yielded up to 2-fold more expression compared to ARCA in DC2.4 and MoDCs.
“CleanCap AG yielded up to 2-fold more expression compared to ARCA in DC2.4 and MoDCs (Figure S4), likely due to higher capping efficiency (up to 98%) and lower dsRNA levels.”
Quote in the paperSubstantial claim- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
- Findingown data
The A/G tail demonstrated superior stability compared to BioNTech's A30L70 tail in bacterial systems.
“This A/G tail demonstrated superior stability compared to BioNTech’s A30L70 tail in bacterial systems while maintaining comparable expression levels of reporter gene in cellulo and in vivo.”
Quote in the paperSubstantial claim - Findingown data
The use of CleanCap AG compared to ARCA cap analog led to decreased dsRNA levels.
“Interestingly, the use of m1Ψ led to decreased dsRNA levels, as did the use of CleanCap AG compared to ARCA cap analog (Table S3).”
Quote in the paperSubstantial claim- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
- Findingown data
The synthetic 5′ UTR UTR4 yielded different results depending on the paired 3′ UTRs, especially in MoDCs.
“However, the synthetic 5′ UTR UTR4 yielded different results depending on the paired 3′ UTRs (Figure 4), especially in MoDCs.”
Quote in the paperSubstantial claim- Rests on an assumption: Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
- Findingown data
The hypothesis that UTR-Fluc ORF interaction leads to unsuitable mRNA folding was confirmed through in vitro translation assays and SRCD analysis.
“We confirmed this hypothesis through in vitro translation assays and SRCD analysis (Figures S3B and S6).”
Quote in the paperSubstantial claim - Findingown data
The A/G tail maintained comparable expression levels of reporter gene in cellulo and in vivo compared to BioNTech's A30L70 tail.
“This A/G tail demonstrated superior stability compared to BioNTech’s A30L70 tail in bacterial systems while maintaining comparable expression levels of reporter gene in cellulo and in vivo.”
Quote in the paperSubstantial claim - Findingown data
Cap-independent 5′ UTRs exhibited a poor translation rate across three different cell lines compared to cap-dependent 5′ UTRs.
“Our results demonstrated that cap-independent 5′ UTRs exhibited a poor translation rate across three different cell lines compared to cap-dependent 5′ UTRs, which is consistent with previous studies showing that IRES are more efficient under stress conditions.42,43”
Quote in the paperSubstantial claim - Findingown data
Purification using oligo dT magnetic beads reduced but did not completely eliminate double-stranded RNA (dsRNA) contamination.
“We demonstrated that purification using oligo dT magnetic beads reduced but did not completely eliminate double-stranded RNA (dsRNA) contamination (Table S3).”
Quote in the paperNot a substantial claim- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
- Findingown data
In vivo immunization tests showed comparable levels of antigen-specific IgG production and neutralizing antibodies across the groups.
“However, in vivo immunization tests showed comparable levels of antigen-specific IgG production and neutralizing antibodies across the groups (Figure 7).”
Quote in the paperSubstantial claim - Findingnone given
The A/G tail yielded similar results in vaccination against SARS-CoV-2.
“Moreover, it yielded similar results in vaccination against SARS-CoV-2.”
Quote in the paperSubstantial claim - Findingown data
By selecting the 3′ UTRs (VP6 and SOD) paired with hAg, protein yields were improved by 40% compared to the benchmark in human muscle cells.
“By selecting the 3′ UTRs, we improved protein yields by 40% compared to the benchmark in human muscle cells (Figure 7).”
Quote in the paperSubstantial claim- Rests on an assumption: Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
- Findingown data
Improved protein production from combinations of three cap-dependent 5′ UTRs (hAg, UTR3, UTR4) with three 3′ UTR sequences (AES, VP6, SOD) in various cellular models was due to increased protein translation efficiency rather than enhanced mRNA stability.
“The evaluation of the combinations of three cap-dependent 5′ UTRs (hAg, UTR3, and UTR4) with three 3′ UTR sequences (AES, VP6, and SOD) in various cellular models revealed that improved protein production was due to increased protein translation efficiency rather than enhanced mRNA stability (Figures 4 and 5).”
Quote in the paperSubstantial claim- Rests on an assumption: Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
- Findingown data
The 5′ UTR hAg yielded similar results regardless of the 3′ UTR sequence across different cell models.
“Our result showed that the 5′ UTR hAg yielded similar results regardless the 3′ UTR sequence across different cell models, suggesting that the 5′ UTR is the primary driver for protein translation from synthetic administered mRNA.”
Quote in the paperSubstantial claim- Rests on an assumption: Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
- Findingown data
The 5′ UTR neoUTR3 paired with the 3′ UTR AES-mtRNR1 yielded different results depending on the ORF used.
“The 5′ UTR neoUTR3 paired with the 3′ UTR AES-mtRNR1 yielded different results depending on the ORF used.”
Quote in the paperSubstantial claim - Interpretationown data
The observed differences in total protein production among UTR combinations can be attributed to ribosome loading rather than mRNA stability or immunogenicity.
“Taken together, these results suggest that the observed differences in total protein production among mRNAs UTR combinations can be attributed to ribosome loading rather than to mRNA stability or immunogenicity.”
Quote in the paperSubstantial claim - Interpretationown data
Expression of the UTR constructs is cell-type dependent.
“Altogether, these results prove that the expression is cell-type dependent, relieving the difficulty in predicting the efficacy of UTR combinations and reinforcing the need for evaluation in cellular and in vivo models.”
Quote in the paperSubstantial claim - Interpretationown data
VP6 and SOD 3′ UTRs are viable alternatives to AES-mtRNR1 in the context of mRNA vaccine development.
“Altogether, these results demonstrate the potential of VP6 and SOD 3′ UTRs, as well as the A/G tail, as viable alternatives to AES-mtRNR1 and A30L70, respectively, in the context of mRNA vaccine development.”
Quote in the paperSubstantial claim - Interpretationown data
The efficiency of mRNA translation depends on the specific combination of 5′ UTR and 3′ UTR sequences, rather than only on the 5′ UTR sequence.
“This polysome profiling analysis revealed that the efficiency of mRNA translation depends on the specific combination of 5′ UTR and 3′ UTR sequences, rather than only on the 5′ UTR sequence.”
Quote in the paperSubstantial claim - Interpretationown data
Cap-dependent 5′ UTRs exhibit significantly higher translation efficiency than cap-independent 5′ UTRs.
“These results illustrated that cap-dependent 5′ UTRs exhibit significantly higher translation efficiency compared to cap-independent 5′ UTRs.”
Quote in the paperSubstantial claim - Interpretationown data
The sequence of the coding region may interfere with the folding of the 5′ UTR and 3′ UTR, leading to a conformation of the mRNA less favorable for translation.
“These results indicate that the sequence of the coding region may interfere with the folding of the 5′ UTR and 3′ UTR, leading to a conformation of the mRNA less favorable for translation.”
Quote in the paperSubstantial claim - Interpretationown data
The selected 3′ UTRs (VP6 and SOD) and heterologous A/G tail have great potential as new elements for therapeutic mRNA design.
“Overall, the selected 3′ UTRs and heterologous A/G tail have great potential as new elements for therapeutic mRNA design.”
- Also stated in: § Evaluation of therapeutic potential · boosted
“Altogether, these results demonstrate the potential of VP6 and SOD 3′ UTRs, as well as the A/G tail, as viable alternatives to AES-mtRNR1 and A30L70, respectively, in the context of mRNA vaccine development.”
Quote in the paperSubstantial claim - Also stated in: § Evaluation of therapeutic potential · boosted
- Interpretationown data
The difference observed in translation potency among the nine mRNAs is not caused by mRNA half-life.
“These results supported similar kinetics decay for the nine mRNA transcripts, indicating that the difference observed in translation potency is not caused by mRNA half-life.”
Quote in the paperSubstantial claim - Interpretationown data
The heterologous A/G tail is as potent as the Pfizer-BioNTech A30L70 tail for mRNA translation.
“Our results showed that the heterologous tail we introduced is as potent as the Pfizer-BioNTech tail and confirmed the high potency of the human α-globin 5′ UTR.”
- Also stated in: § Alternative poly(A) tail · boosted
“These results demonstrate that the A/G tail is as potent as A30L70 and represents a viable alternative for mRNA design.”
Quote in the paperSubstantial claim - Also stated in: § Alternative poly(A) tail · boosted
- Premisecitation
Guanosine residues are the most frequent non-adenosine nucleotides in poly(A) tails in humans and other species.
“Guanosine residues are the most frequent non-adenosine nucleotides in poly(A) tails in humans and other species.20,21”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [20] Lim, 2018, Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation, Science source
- cites [21] Chang, 2014, TAIL-seq: Genome-wide Determination of Poly(A) Tail Length and 3′ End Modifications, Mol. Cell source
Checked before — its earlier verdict is held back until a new check runs.
- Interpretationown data
The A/G tail is a viable alternative for mRNA design.
“These results demonstrate that the A/G tail is as potent as A30L70 and represents a viable alternative for mRNA design.”
Quote in the paperSubstantial claim - Interpretationown data
The A30L70 and A/G tails have comparable structural properties.
“The structural analysis revealed that the A30L70 and A/G tails exhibited a similar Tm and SRCD profiles, suggesting comparable structural properties.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Factors regulating translation and mRNA stability are cell-type-specific.
“In contrast to previous studies that optimize mRNA domains separately, our study highlights the importance of considering the entire mRNA sequence, the production parameters of IVT mRNA, and the target cell types of the desired application, as factors regulating translation and mRNA stability are cell-type-specific.”
Quote in the paperSubstantial claim- Rests on an assumption: Translation efficiency and mRNA stability of synthetic mRNA are directly linked to its design elements (Cap, UTR, codon usage, and poly(A) tail), IVT parameters, and downstream purification.
- Rests on an assumption: Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
- Interpretationown data
Ribosome load on mRNA is influenced by the 5′ and 3′ UTR base-pairing interactions.
“This observation is supported by the polysome profiling results (Figure 5), suggesting that ribosome load on mRNA is influenced by the 5′ and 3′ UTR base-pairing interactions.”
Quote in the paperSubstantial claim - Interpretationcitation
Open reading frame (ORF) may affect the mRNA secondary structure and, consequently, impact its translation efficiency.
“The in vivo evaluation of these 5′ and 3′ UTR combinations highlighted the fact that open reading frame (ORF) may affect the mRNA secondary structure and, consequently, impact its translation efficiency.45”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [45] Bicknell, 2024, Attenuating ribosome load improves protein output from mRNA by limiting translation-dependent mRNA decay, Cell Rep. source
Checked before — its earlier verdict is held back until a new check runs.
- Premisecitation
The instability of the traditional poly(A) tail during plasmid amplification in bacterial systems presents a significant challenge in mRNA production.
“The instability of the traditional poly(A) tail during plasmid amplification in bacterial systems presents a significant challenge in mRNA production.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Grier, 2016, pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences, Mol. Ther. Nucleic Acids source
Checked before — its earlier verdict is held back until a new check runs.
- Interpretationown data
The 5′ UTR is the primary driver for protein translation from synthetic administered mRNA.
“Our result showed that the 5′ UTR hAg yielded similar results regardless the 3′ UTR sequence across different cell models, suggesting that the 5′ UTR is the primary driver for protein translation from synthetic administered mRNA.”
Quote in the paperSubstantial claim - Interpretationcitation
A possible explanation for the ORF-dependent difference is the interaction between the UTRs and the Fluc ORF, leading to mRNA folding that is not suitable for efficient translation.
“A possible explanation is the interaction between the UTRs and the Fluc ORF, leading to mRNA folding that is not suitable for efficient translation.46”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46] Lewis, 2025, Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs, Mol. Cell source
Checked before — its earlier verdict is held back until a new check runs.
- Interpretationcitation
The enhanced performance of the A/G tail may be attributed to increased mRNA stability within cells.
“The enhanced performance of the A/G tail may be attributed to increased mRNA stability within cells.”
Quote in the paperSubstantial claim - Study design and conductown data
Transfection with LFM did not induce detectable cytotoxicity.
“Transfection with LFM did not induce detectable cytotoxicity (Figure S9).”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 25
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe IRES from Cricket paralysis virus (CrPV) is able to directly recruit the 60S subunit.
“the IRES from Cricket paralysis virus (CrPV) that is able to directly recruit the 60S subunit.29”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Gross, 2017, The IRES5′UTR of the dicistrovirus cricket paralysis virus is a type III IRES containing an essential pseudoknot structure, Nucleic Acids Res. source
The Introduction (page unavailable) says type III IRESs bind directly to the 40S ribosomal subunit, and the paper identifies the CrPV 5′UTR IRES as type III. It does not say that this IRES directly recruits the 60S subunit; the specified subunit is contrary to the claim. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationGuanylation stabilizes mRNA by reducing deadenylation, and cellular mRNAs with non-A tails are highly translated.
“Furthermore, guanylation has been reported to stabilize mRNA by reducing deadenylation20,22 and that cellular mRNAs with non-A tails are highly translated.22”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationThe interactions between 5′ and 3′ UTR are crucial and can modulate the mRNA translation efficiency.
“The interactions between 5′ and 3′ UTR are crucial and can modulate the mRNA translation efficiency.44”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [44] Kirshina, 2023, Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA, Biomolecules source
The Discussion reports that combinations of 5′ and 3′ UTRs affected protein expression, primarily through translational efficiency. But the Conclusions describe their influence on each other as indirect, and the Introduction says they do not interact directly during translation. The claim overstates the evidence by calling their interactions crucial without that qualification. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationThe human Hsp70 5′ UTR is reported to be a general enhancer of mRNA translation.
“the human Hsp70 5′ UTR reported to be a general enhancer of mRNA translation26”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [26] Vivinus, 2001, An element within the 5′ untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation, Eur. J. Biochem. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe CleanCap AG trinucleotide cap analog is used in the Pfizer-BioNTech vaccine.
“we also evaluated the translatability of three mRNAs harboring the CleanCap AG trinucleotide cap analog used in the Pfizer-BioNTech vaccine.37,38”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [37] Warminski, 2023, Chemical Modifications of mRNA Ends for Therapeutic Applications, Acc. Chem. Res. source
The “How to Cap RNA” section says trinucleotide cap analogs are sold as CleanCap reagents and that a modified trinucleotide cap was used to produce the Comirnaty vaccine. It does not identify that vaccine cap as CleanCap AG, so the specific product attribution is unsupported. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [38] Sahin, 2020, COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, Nature source
The Manufacturing of RNA section says the Pfizer–BioNTech vaccine candidate BNT162b1 used a TriLink trinucleotide cap 1 analogue with the stated chemical structure. The Article section says a different candidate, BNT162b2, was selected to advance to phase II/III. This paper therefore supports use of a trinucleotide cap in BNT162b1, but does not establish that the marketed Pfizer–BioNTech vaccine uses CleanCap AG; it also does not name the cap as CleanCap AG. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVaccination is the only approved application of synthetic mRNA.
“Vaccination is the only approved application of synthetic mRNA.2,4”
Quote in the paperNot a substantial claim2 of 2 sources checkedMay combine two claims.
PremisecitationThe Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin and the 3′ UTR AES-mtRNR1 combination.
“the Pfizer-BioNTech mRNA vaccine contains the 5′ UTR of human α-globin, which was identified as one of the top 20% 5′ UTRs in massive screening studies,10,11,13 and the 3′ UTR AES-mtRNR1 combination of two genes, AES (Amino Enhancer of Split) and mtRNR1 (12S mitochondrial RNA).12”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [10] Castillo-Hair, 2024, Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning, Nat. Commun. source
The Introduction says many mRNA therapies use alpha- or beta-globin UTRs. The Results section on de novo designed 5′UTRs places the commonly used beta-globin UTR—not alpha-globin—in the top ~20% of short endogenous UTRs. This paper therefore does not establish the cited ranking for alpha-globin or identify it as the Pfizer-BioNTech vaccine’s 5′UTR; the sentence cites a different source for the 3′UTR combination. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [11] Sample, 2019, Human 5′ UTR design and variant effect prediction from a massively parallel translation assay, Nat. Biotechnol. source
The Results (MPRA design and validation) and Online Methods (Design and Synthesis of varying Lengths 5′ UTR Sequences) describe large-scale screening of human 5′ UTRs, but the passages found do not identify α-globin’s UTR as being in the top 20% or discuss the Pfizer-BioNTech vaccine. Searches for globin, HBA1/HBA2, the top-20% ranking, and the vaccine found no passage establishing those points. The AES-mtRNR1 portion of the citing sentence is attached to a different citation. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [13] Xia, 2021, Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines, Vaccines source
May combine two claims.
PremisecitationThe Hsp70 5′ UTR has an enhancer element and can promote translation via both cap-dependent and cap-independent mechanisms.
“The higher expression of Hsp70 5′ UTR-mRNA in DC 2.4 may be attributed to an enhancer element in its sequence and to its capability to promote translation via both cap-dependent and cap-independent mechanisms.26,31”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [26] Vivinus, 2001, An element within the 5′ untranslated region of human Hsp70 mRNA which acts as a general enhancer of mRNA translation, Eur. J. Biochem. source
The Abstract identifies a human Hsp70 5′ UTR element that enhances translation, and the Discussion says it improves translation during cap-dependent protein synthesis. The section “The Hsp70 5′ UTR does not behave as an IRES” reports no IRES activity; the Discussion leaves translation when cap-dependent synthesis is downregulated as an open question. This paper therefore does not support the cap-independent part of the claim. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [31] Rubtsova, 2003, Distinctive Properties of the 5′-Untranslated Region of Human Hsp70 mRNA, J. Biol. Chem. source
The Discussion reports that the Hsp70 5′ UTR contains a strong IRES and directs cap-independent translation. It also notes an enhancing effect on reporter translation in monocistronic constructs. The paper does not establish that the UTR promotes translation through a cap-dependent mechanism as well, so the claim about both mechanisms is not fully supported. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIRES elements are known to function more effectively under stress conditions.
“as IRES elements are known to function more effectively under stress conditions.30”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [30] Godet, 2019, IRES Trans-Acting Factors, Key Actors of the Stress Response, Int. J. Mol. Sci. source
May combine two claims.
PremisecitationThe study by Liu et al. did not evaluate stability of templates nor translation efficiency in human primary cells or in vivo.
“This study did not evaluate stability of templates nor translation efficiency in human primary cells or in vivo.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [22] Liu, 2021, Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails, bioRxiv source
The cell-culture and transfection Methods describe translation experiments in HeLa cells, not human primary cells, and the paper does not report an in vivo test of the engineered mRNAs. But the 'Non-A residues promote translation efficiency of IVT mRNA' section uses qPCR to assess whether increased protein production reflects mRNA stability, while the 'non-A residues are associated with high translation efficiency in vivo' section analyzes translation efficiency of endogenous mRNAs in mouse oocytes. The blanket statement that the study did not evaluate template stability or translation efficiency in vivo is therefore too broad. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataAll tested mRNAs exhibited similar time-dependent decay and comparable half-life, except hAg-VP6, which seemed slightly more stable than the benchmark especially after 96 h.
“All tested mRNAs exhibited a similar time-dependent decay and a comparable half-life, except for mRNA hAg-VP6, which seemed to be slightly more stable than the benchmark mRNA, especially after 96 h (Figures 5A and 5B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn HeLa cells, hAg-AES, hAg-VP6, and UTR4-AES mRNAs showed more pronounced association with polysomes, while UTR3-SOD and UTR4-SOD showed lower association (less than 25%).
“Notably, hAg-AES, hAg-VP6, and UTR4-AES showed more pronounced association with polysomes, while UTR3-SOD and UTR4-SOD showed lower association (less than 25%) (Figure 5D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeutralizing antibody responses were similar across groups, with a marked increase following the booster injection.
“While there were some variations in IgG production, neutralizing antibody responses were similar across groups, with a marked increase following the booster injection (Figure 7D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe Hsp70 5′ UTR exhibited lower translation efficiency than α-globin in C2C12 cells, equivalent performance in HeLa cells, and superior translation in DC2.4 cells.
“Interestingly, the performance of the Hsp70 5′ UTR varied among the three cell lines: it exhibited lower translation efficiency than α-globin in C2C12 cells, equivalent performance in HeLa cells, and superior translation in DC 2.4 cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPreheated UTR3-AES Fluc mRNA produced two times more protein than unheated mRNA, whereas UTR3-VP6 Fluc mRNA produced the same amount regardless of preheating.
“Interestingly, the preheated UTR3-AES Fluc mRNA produced two times more protein than the unheated mRNA, whereas UTR3-VP6 Fluc mRNA produced the same amount of protein regardless of preheating (Figure S3B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn AB1079 human myoblasts, UTR3-SOD and UTR4-VP6 produced 25% less protein and UTR4-SOD produced less than 50% of the protein compared to the benchmark hAg-AES.
“The results in AB1079 cells mirrored the pattern obtained in C2C12 cells, except for UTR3-SOD, UTR4-VP6, which produced 25% less protein, and UTR4-SOD mRNA, which produced less than 50% of the protein compared to the benchmark mRNA (Figure 4F).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataIn BALB/c mice, A/G tail produced only 10% less total protein than A30L70.
“The AUC analysis revealed that A/G tail produced only 10% less total protein compared to A30L70 (Figure 2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn DC2.4 cells, UTR4-SOD mRNA was translated 2-fold less than the benchmark, while other mRNAs showed similar protein expression.
“Remarkably, in DC 2.4, we found that the UTR4-SOD mRNA pair was translated 2-fold less than the benchmark, while the other mRNAs showed similar protein expression (Figure 4E).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn E. coli, the A/G tail had 100% clone integrity after 10 passages, compared with 90% for A30L70 and 10% for A120.
“We found that only 10% of the clones with A120 tail retained the full 120A tract, confirming the reported instability of homopolymeric A tails.17 In contrast, the A30L70 and A/G tails demonstrated high stability, with 90% and 100% of clones keeping the integrity of the poly(A) tail, respectively (Figure 1B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn HeLa cells, eight of the nine 5′ UTR-3′ UTR combinations tested had similar translation kinetics and total protein production over time; UTR4-SOD produced less protein than the benchmark hAg-AES.
“As shown in Figures 4B and 4C, eight of the nine combinations tested had similar translation kinetics and total protein production over time in HeLa cells. The UTR4-SOD mRNA was the only mRNA that produced less protein than the benchmark.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn MoDCs, five of the nine mRNAs (hAg-AES, hAg-VP6, hAg-SOD, UTR3-AES, and UTR4-AES) were similarly translated, while mRNA with 3′ UTR VP6 or SOD in combination with UTR3 or UTR4 5′ UTRs resulted in decreased translation.
“In MoDCs, five of the nine mRNAs tested were similarly translated (hAg-AES, hAg-VP6, hAg-SOD, UTR3-AES, and UTR4-AES), and mRNA with 3′ UTR VP6 or SOD in combination with UTR3 or UTR4 5′ UTRs resulted in decreased mRNA translation (Figure 4G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe A/G tail showed a tendency of higher IgG production after 2 and 3 weeks compared to the A30L70 tail, although the difference was not statistically significant.
“Regarding the tails, the A/G tail revealed a tendency of higher IgG production after 2 and 3 weeks compared to the A30L70 tail, although the difference was not statistically significant (Figures 7F and 7G).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAll nine UTR constructs had the same percentage of dsRNA content and induced comparable activation of the interferon pathway in DC2.4 cells.
“However, all the constructs had the same percentage of dsRNA content (Table S2) and induced comparable activation of the interferon pathway in DC2.4 cells (Figure S2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn BALB/c mice, total protein production from the eight UTR combinations reached equivalent levels except for UTR3-AES mRNA, which produced 10-fold less protein than hAg-AES mRNA.
“Total protein production reached equivalent levels for all mRNAs except for UTR3-AES mRNA, which produced 10-fold less protein than hAg-AES mRNA (Figure 6).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe A30L70 and A/G tails exhibited similar Tm and SRCD profiles.
“The structural analysis revealed that the A30L70 and A/G tails exhibited a similar Tm and SRCD profiles, suggesting comparable structural properties.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingreasoningWith nanoluciferase ORF, protein levels from neoUTR3/AES-mtRNR1 were similar to the benchmark, whereas with firefly luciferase ORF, they were 10-fold lower compared to the benchmark in vivo.
“With nanoluciferase ORF, protein levels were similar to the benchmark, whereas with firefly luciferase ORF, they were 10-fold lower compared to the benchmark in vivo.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationPoly(A) stretches of 30 and 70 adenosines separated by a 10 nt linker (A30L70 tail) resulted in more stable poly(A) tails on plasmid templates.
“BioNTech demonstrated that poly(A) stretches of 30 and 70 adenosines separated by a 10 nt linker (A30L70 tail) resulted in more stable poly(A) tails on plasmid templates.18”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] EBERLE, 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataUTR3-AES Fluc mRNA is structured and potentially less accessible to the ribosome.
“suggesting that UTR3-AES Fluc mRNA is structured and potentially less accessible to the ribosome (Figure S7).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationThe poly(A) tail protects mRNA from degradation and is required to form a closed loop between the 5′ and 3′ ends that stimulates translation.
“It protects the mRNA from degradation15 and is required to form a closed loop between the 5′ and 3′ ends of the mRNA, a conformation that stimulates translation.16”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Study design and conductown dataThe resulting LNPs measured 95-120 nm with a PDI <0.2 and exhibited an encapsulation efficiency of 90%-95%.
“The resulting LNPs measured 95–120 nm with a PDI <0.2 (Figure S10) and exhibited an encapsulation efficiency of 90%–95% (data not shown).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll animal procedures were approved by the French Ministry of Research.
“All animal procedures were approved by the French Ministry of Research (#30279 for intramuscular injection of luciferase mRNA, #44268 for immunization with Spike mRNA).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe higher expression with CleanCap AG is likely due to higher capping efficiency (up to 98%) and lower dsRNA levels.
“CleanCap AG yielded up to 2-fold more expression compared to ARCA in DC2.4 and MoDCs (Figure S4), likely due to higher capping efficiency (up to 98%) and lower dsRNA levels.”
Quote in the paperSubstantial claim- Rests on an assumption: The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe LNP composition used was the same as the Pfizer-BioNTech vaccine.
“LNPs with the same composition as the Pfizer-BioNTech vaccine23 were used to deliver A30L70- or A/G-tailed mRNA encoding firefly luciferase (Fluc) by intramuscular injection”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Sosnick, 2001, Characterization of Tertiary Folding of RNA by Circular Dichroism and Urea, Curr. Protoc. Nucleic Acid Chem. source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe constructs were verified by restriction enzyme analysis and Sanger sequencing.
“The constructs were verified by restriction enzyme analysis and Sanger sequencing performed by Eurofins (Ebersberg, Germany).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisenone givenThe benchmark Comirnaty uses hAg-AES with A30L70 tail.
“the benchmark Comirnaty (hAg-AES with A30L70 tail)”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCOVID-19 vaccines required intramuscular administration of mRNA-LNP and expression of the mRNA-encoded antigen in antigen-presenting cells such as dendritic cells to induce a protective immune response.
“COVID-19 vaccines required intramuscular administration of mRNA-LNP and expression of the mRNA-encoded antigen in antigen-presenting cells such as dendritic cells (DC) to induce a protective immune response.34”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Kuhn, 2011, Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics, RNA Biol. source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll cell lines were confirmed mycoplasma-free using the MycoAlert Mycoplasma Detection Kit.
“All cell lines were confirmed mycoplasma-free using the MycoAlert Mycoplasma Detection Kit (Lonza).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSpectral magnitudes were calibrated using a solution of camphorsulfonic acid (CSA) at a known concentration.
“Spectral magnitudes were calibrated using a solution of camphorsulfonic acid (CSA) at a known concentration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe integrity and quality of the purified mRNA was verified by capillary electrophoresis using an Agilent 2100 Bioanalyzer.
“The integrity and quality of the purified mRNA was verified by capillary electrophoresis using an Agilent 2100 Bioanalyzer.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationmRNA tails containing C and G residues were more efficiently translated than mRNA with pure A tails in HeLa cells.
“A recent study by Liu et al. reported that mRNA tails containing C ang G residues were more efficiently translated than mRNA with pure A tails in HeLa cells.22”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Liu, 2021, Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails, bioRxiv source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIntegrity of poly(A) tails was verified by Sanger sequencing.
“Integrity of tails was verified by Sanger sequencing performed by Eurofins (Ebersberg, Germany).”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Predicting the optimal combination of 5′ and 3′ UTR remains challenging due to tissue and cell-type dependencies, and RNA folding of UTRs, which can be affected by the coding sequence.
“However, predicting the optimal combination of 5′ and 3′ UTR remains challenging due to tissue and cell-type dependencies, and RNA folding of UTRs, which can be affected by the coding sequence.”
The paper relies on this without support.
The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation.
“The efficacy of mRNA technology depends on both the efficiency of mRNA delivery and translation.”
The paper relies on this without support.
Translation efficiency and mRNA stability of synthetic mRNA are directly linked to its design elements (Cap, UTR, codon usage, and poly(A) tail), IVT parameters, and downstream purification.
“Translation efficiency and mRNA stability of synthetic mRNA are directly linked to its design elements (Cap, UTR, codon usage, and poly(A) tail), IVT parameters, and downstream purification.”
The paper relies on this without support.
Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.
“Another key element in mRNA translation efficiency and stability is the 5′ and 3′ UTRs.”
The paper relies on this without support.
The parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.
“In addition to optimizing synthetic mRNA sequences, the parameters of the IVT and the choice of downstream purification are crucial for improved translation efficiency.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inclusion of specific untranslated regions is a promising strategy to enhance stability and efficacy of mRNA therapeutics.
“Recent studies demonstrate that, in addition to the incorporation of modified nucleosides, the inclusion of specific untranslated regions represents a highly promising strategy to enhance the stability and efficacy of mRNA therapeutics [12][13][14][15][16].”
From Identification of novel 5’ UTR variants for enhanced mRNA translation and vaccine immunogenicity (2026) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 1B is cited for two different measurements
MinorThe results cite Figure 1B for bacterial tail stability, but the figure caption assigns tail stability to panel A and melting temperatures to panel B.
“with 90% and 100% of clones keeping the integrity of the poly(A) tail, respectively (Figure 1B).”
“(B) Melting temperatures (Tm) of mRNA tails determined by SRCD analysis.”
The first mouse immunization is assigned two different days
MinorThe results place the first injection on day 0, while the methods place it on day 1.
“Mice were immunized twice (on days 0 and 14)”
“LNPs were injected into the tibialis muscle on days 1 and 14.”
The number of 5′ UTRs screened changes from six to seven
MinorThe abstract says six 5′ UTRs were screened, whereas the introduction says seven were compared.
“First, we screened six 5′ UTRs (cap-dependent/-independent)”
“We then compared the translation efficiency of seven different 5′ UTRs from mammalian, viral, and synthetic origins in three different cell lines.”
The poorly performing Fluc combination is named inconsistently
MinorThe passage identifies UTR3-AES as the combination with poor Fluc expression, then calls it UTR3-SOD when introducing the investigation of that result.
“To investigate this unexpected poor performance of UTR3-SOD Fluc mRNA, we conducted an in vitro translation assay using preheated and unheated mRNA.”
“Total protein production reached equivalent levels for all mRNAs except for UTR3-AES mRNA, which produced 10-fold less protein than hAg-AES mRNA (Figure 6).”
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977 · see citing works
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Hall, M. P., Unch, J., Binkowski, B. F., Valley, M. P., Butler, B. L., Wood, M. G., Otto, P., Zimmerman, K., Vidugiris, G. J. A., Machleidt, T., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb3002478 · Cited by 1,588 · see citing works
Translational control by 5′-untranslated regions of eukaryotic mRNAs
Hinnebusch, A. G., Ivanov, I. P., & Sonenberg, N. (2016) · Science · doi:10.1126/science.aad9868 · Cited by 1,079 · see citing works
The clinical progress of mRNA vaccines and immunotherapies
Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R., & Anderson, D. G. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01294-2 · Cited by 823 · see citing works
Short RNAs Repress Translation after Initiation in Mammalian Cells
Petersen, C. P., Bordeleau, M.-È., Pelletier, J., & Sharp, P. A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.031 · Cited by 755 · see citing works
Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen, Z., Reznikoff, G., Dranoff, G., & Rock, K. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2723 · Cited by 702 · see citing works
Mayr, C. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034728 · Cited by 519 · see citing works
The promise of mRNA vaccines: a biotech and industrial perspective
Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020) · npj Vaccines · doi:10.1038/s41541-020-0159-8 · Cited by 498 · cited 1× · see citing works
“1,2 Synthetic mRNA has the same primary structure as mature mRNA molecules, typically consisting of five elements (from 5 ′ to 3 ′ ): a cap structure, a 5 ′ untranslated region (5 ′ UTR), a coding sequence, a 3 ′ UTR, and the poly(A) tail.”
TAIL-seq: Genome-wide Determination of Poly(A) Tail Length and 3′ End Modifications
Chang, H., Lim, J., Ha, M., & Kim, V. N. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.007 · Cited by 454 · see citing works
Human 5′ UTR design and variant effect prediction from a massively parallel translation assay
Sample, P. J., Wang, B., Reid, D. W., Presnyak, V., McFadyen, I. J., Morris, D. R., & Seelig, G. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0164-5 · Cited by 442 · see citing works
Multifunctional deadenylase complexes diversify mRNA control
Goldstrohm, A. C., & Wickens, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2370 · Cited by 377 · see citing works
Orlandini von Niessen, A. G., Poleganov, M. A., Rechner, C., Plaschke, A., Kranz, L. M., Fesser, S., Diken, M., Löwer, M., Vallazza, B., Beissert, T., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.011 · Cited by 365 · see citing works
Mamchaoui, K., Trollet, C., Bigot, A., Négroni, E., Chaouch, S., Wolff, A., Kandalla, P. K., Marie, S., Santo, J. P. D., Guily, J. L. S., et al. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-34 · Cited by 338 · see citing works
Self-citationSystematic discovery of cap-independent translation sequences in human and viral genomes
Weingarten-Gabbay, S., Elias-Kirma, S., Nir, R., Gritsenko, A. A., Stern-Ginossar, N., Yakhini, Z., Weinberger, A., & Segal, E. (2016) · Science · doi:10.1126/science.aad4939 · Cited by 334 · see citing works
Svitkin, Y. V., Cheng, Y. M., Chakraborty, T., Presnyak, V., John, M., & Sonenberg, N. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx135 · Cited by 278 · see citing works
IRES Trans-Acting Factors, Key Actors of the Stress Response
Godet, A.-C., David, F., Hantelys, F., Tatin, F., Lacazette, E., Garmy-Susini, B., & Prats, A.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040924 · Cited by 202 · see citing works
Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
Xia, X. (2021) · Vaccines · doi:10.3390/vaccines9070734 · Cited by 201 · see citing works
Translation factors promote the formation of two states of the closed-loop mRNP
Amrani, N., Ghosh, S., Mangus, D. A., & Jacobson, A. (2008) · Nature · doi:10.1038/nature06974 · Cited by 200 · see citing works
Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation
Lim, J., Kim, D., Lee, Y.-S., Ha, M., Lee, M., Yeo, J., Chang, H., Song, J., Ahn, K., & Kim, V. N. (2018) · Science · doi:10.1126/science.aam5794 · Cited by 165 · see citing works
High-throughput 5’ UTR engineering for enhanced protein production in non-viral gene therapies
Cao, J., Novoa, E. M., Zhang, Z., Chen, W. C. W., Liu, D., Choi, G. C. G., Wong, A. S. L., Wehrspaun, C., Kellis, M., & Lu, T. K. (2021) · Nature Communications · doi:10.1038/s41467-021-24436-7 · Cited by 159 · see citing works
Leveraging mRNA Sequences and Nanoparticles to Deliver SARS‐CoV‐2 Antigens In Vivo
Zeng, C., Hou, X., Yan, J., Zhang, C., Li, W., Zhao, W., Du, S., & Dong, Y. (2020) · Advanced Materials · doi:10.1002/adma.202004452 · Cited by 152 · see citing works
Miles, A. J., & Wallace, B. A. (2018) · Protein Science · doi:10.1002/pro.3474 · Cited by 144 · see citing works
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139 · see citing works
Self-citationBranched chemically modified poly(A) tails enhance the translation capacity of mRNA
Chen, H., Liu, D., Guo, J., Aditham, A. J., Zhou, Y., Tian, J., Luo, S., Ren, J., Hsu, A., Huang, J., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02174-7 · Cited by 129 · see citing works
Distinctive Properties of the 5′-Untranslated Region of Human Hsp70 mRNA
Rubtsova, M. P., Sizova, D. V., Dmitriev, S. E., Ivanov, D. S., Prassolov, V. S., & Shatsky, I. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303213200 · Cited by 100 · see citing works
Arrigucci, R., Bushkin, Y., Radford, F., Lakehal, K., Vir, P., Pine, R. I., Martin, D., Sugarman, J., Zhao, Y., Yap, G. S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.039 · Cited by 100 · see citing works
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Kang, D. D., Li, H., & Dong, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114961 · Cited by 100 · see citing works
Optimizing 5’UTRs for mRNA-delivered gene editing using deep learning
Castillo-Hair, S., Fedak, S., Wang, B., Linder, J., Havens, K., Certo, M., & Seelig, G. (2024) · Nature Communications · doi:10.1038/s41467-024-49508-2 · Cited by 98 · see citing works
pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences
Grier, A. E., Burleigh, S., Sahni, J., Clough, C. A., Cardot, V., Choe, D. C., Krutein, M. C., Rawlings, D. J., Jensen, M. C., Scharenberg, A. M., et al. (2016) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2016.21 · Cited by 95 · see citing works
Chemical Modifications of mRNA Ends for Therapeutic Applications
Warminski, M., Mamot, A., Depaix, A., Kowalska, J., & Jemielity, J. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00442 · Cited by 91 · see citing works
A Biopharmaceutical Perspective on Higher-Order Structure and Thermal Stability of mRNA Vaccines
Kloczewiak, M. A., Banks, J. M., Jin, L., & Brader, M. L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00092 · Cited by 89 · see citing works
Bicknell, A. A., Reid, D. W., Licata, M. C., Jones, A. K., Cheng, Y. M., Li, M., Hsiao, C. J., Pepin, C. S., Metkar, M., Levdansky, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114098 · Cited by 68 · see citing works
Vivinus, S., Baulande, S., van Zanten, M., Campbell, F., Topley, P., Ellis, J. H., Dessen, P., & Coste, H. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02064.x · Cited by 67 · see citing works
Imai, S., Kumar, P., Hellen, C. U. T., D’Souza, V. M., & Wagner, G. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3280 · Cited by 64 · see citing works
Understanding the impact of in vitro transcription byproducts and contaminants
Lenk, R., Kleindienst, W., Szabó, G. T., Baiersdörfer, M., Boros, G., Keller, J. M., Mahiny, A. J., & Vlatkovic, I. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1426129 · Cited by 63 · see citing works
Linares-Fernández, S., Moreno, J., Lambert, E., Mercier-Gouy, P., Vachez, L., Verrier, B., & Exposito, J.-Y. (2021) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2021.10.007 · Cited by 62 · see citing works
Coutant, E. P., Goyard, S., Hervin, V., Gagnot, G., Baatallah, R., Jacob, Y., Rose, T., & Janin, Y. L. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00459a · Cited by 54 · see citing works
Gross, L., Vicens, Q., Einhorn, E., Noireterre, A., Schaeffer, L., Kuhn, L., Imler, J.-L., Eriani, G., Meignin, C., & Martin, F. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx622 · Cited by 53 · see citing works
Licursi, M., Christian, S. L., Pongnopparat, T., & Hirasawa, K. (2011) · Gene Therapy · doi:10.1038/gt.2011.11 · Cited by 52 · see citing works
Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics
Kuhn, A. N., Diken, M., Kreiter, S., Vallazza, B., Türeci, Ö., & Sahin, U. (2011) · RNA Biology · doi:10.4161/rna.8.1.13767 · Cited by 39 · see citing works
Chung, D. J., Wright, A., & Clerch, L. B. (1998) · Biochemistry · doi:10.1021/bi980935g · Cited by 38 · see citing works
Medjmedj, A., Loth, A. N., Clémençon, R., Hamáček, J., Pichon, C., & Perche, F. (2022) · Nanomaterials · doi:10.3390/nano12142446 · Cited by 38 · see citing works
Self-citationDmitriev, S. E., Andreev, D. E., Adyanova, Z. V., Terenin, I. M., & Shatsky, I. N. (2009) · Molecular Biology · doi:10.1134/s0026893309010154 · Cited by 37 · see citing works
Wang, P., Perche, F., Midoux, P., Cabral, . S. D., Malard, V., Correia, I. J., El‐Hafci, H., Petite, H., Logeart‐Avramoglou, D., & Pichon, C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.021 · Cited by 36 · see citing works
Self-citationCharacterization of Tertiary Folding of <scp>RNA</scp> by Circular Dichroism and Urea
Sosnick, T. R. (2001) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc1105s04 · Cited by 30 · see citing works
Lewis, C. J. T., Xie, L. H., Bhandarkar, S. M., Jin, D., Abdallah, K., Draycott, A. S., Chen, Y., Thoreen, C. C., & Gilbert, W. V. (2025) · Molecular Cell · doi:10.1016/j.molcel.2024.11.030 · Cited by 28 · see citing works
Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA
Kirshina, A., Vasileva, O., Kunyk, D., Seregina, K., Muslimov, A., Ivanov, R., & Reshetnikov, V. (2023) · Biomolecules · doi:10.3390/biom13111677 · Cited by 26 · see citing works
Dmitriev, S. E., Andreev, D. E., Adyanova, Z. V., Terenin, I. M., & Shatskiĭ, I. N. (2009) · PubMed · Cited by 23 · see citing works
Quantitative analysis of m6A RNA modification by LC-MS
Mathur, L., Jung, S., Jang, C., & Lee, G. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100724 · Cited by 23 · see citing works
Burman, L., & Mauro, V. P. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks530 · Cited by 22 · see citing works
Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution
Lee, Y.-S., Levdansky, Y., Jung, Y., Kim, V. N., & Valkov, E. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01187-1 · Cited by 21 · see citing works
SRCD and FTIR Spectroscopies to Monitor Protein-Induced Nucleic Acid Remodeling
Wien, F., Geinguenaud, F., Grange, W., & Arluison, V. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0935-4_6 · Cited by 18 · see citing works
Self-citationMorita, M., Alain, T., Topisirović, I., & Sonenberg, N. (2013) · BIO-PROTOCOL · doi:10.21769/bioprotoc.833 · Cited by 17 · see citing works
Gebauer, F., & Hentze, M. W. (2016) · Science · doi:10.1126/science.aad8540 · Cited by 11 · see citing works
Liu, Y., Nie, H., Sun, R., Ma, X., Wang, J., & Lu, F. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3078-0 · Cited by 11 · see citing works
Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails
Liu, Y., Nie, H., Sun, R., Wang, J., & Lu, F. (2021) · doi:10.1101/2021.08.30.458298 · Cited by 11 · see citing works
Yang, A.-D., Barro, M., Gorziglia, M. I., & Patton, J. T. (2004) · Archives of Virology · doi:10.1007/s00705-003-0211-9 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nanopore direct RNA sequencing and the epitranscriptome: Advances in mapping native RNA landscapes
Zhang, T., Li, J., Tang, C., Wu, Y., Wu, H., Xi-Tong, Z., Luo, Z., Qin, H., Ding, L., Zeng, Y., et al. (2026) · iMeta · doi:10.1002/imt2.70136 · Cited by 15 · see citing works
Yadav, V., Yadav, P., Mallappa, S., & Neeli, P. (2026) · Biomedicines · doi:10.3390/biomedicines14061276 · Cited by 3 · see citing works
Farzani, T. A., Espinoza, N., Manafi, M. M., Welch, S. R., Coleman-McCray, J. D., Aida-Ficken, V., Spengler, J. R., Bergeron, É., Spiropoulou, C. F., Borges, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.17.699915 · Cited by 2 · see citing works
Ortega-Méndez, J., Rojas, J., White, A. C., & Castellanos-González, A. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag302 · Cited by 1 · see citing works
MicroRNAs as diagnostic prognostic and therapeutic biomarkers in glioblastoma
Javaid, S., Shahid, S., & Ali, N. (2026) · Discover Oncology · doi:10.1007/s12672-026-04858-9 · Cited by 1 · see citing works
Identification of novel 5’ UTR variants for enhanced mRNA translation and vaccine immunogenicity
Mazunina, E. P., Dzharullaeva, A. S., Kleymenov, D. A., Bykonia, E. N., Kozlova, S. R., Usachev, E. V., Panova, E. A., Konopleva, M. V., Telegina, D. V., Kukushkina-Zvezdova, A. A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-59586-5
Engineering bone tissue with mRNA: from molecular design and delivery to clinical applications
Runzer, C. D. T., van Griensven, M., & Balmayor, E. R. (2025) · Materials Today · doi:10.1016/j.mattod.2025.11.002
Cagnin, S. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102879
A single-nucleotide change in the Kozak sequence enhances protein expressionPreprint
Knol, R. A., Fariaby, T., de Vlieger, E. A., Kros, A., & Slütter, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726450
Lin, J. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2026-0120
Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field
Slarve, M. J., Tkaczyk, C., Doyle, M. P., Break, T. J., Smith, A. B., Alter, G., Luna, B. M., Spellberg, B. J., & DiGiandomenico, A. (2026) · BioDrugs · doi:10.1007/s40259-026-00787-9
dos Santos, V. K., & Costa, A. D. O. (2026) · Revista Sociedade Científica · doi:10.61411/rsc2026136519
Sajjanar, B., Gopinath, S., Nadarajan, P., Marreddy, V. K., Krishnaswamy, N., Nagaleekar, V. K., Hosamani, M., Sreenivasa, B. P., Chaudhuri, P., & Basagoudanavar, S. H. (2026) · Biotechnology Letters · doi:10.1007/s10529-026-03778-6
Nair, A., & Kis, Z. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.109034
mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers
Ghidini, M., Novazzi, F., Denaro, N., Petrillo, A., Ratti, M., Salati, M., Malvaso, R., Marco, L. D., Parisi, A., & Hahne, J. C. (2026) · Cells · doi:10.3390/cells15181673
Programmable mRNA Nanotherapeutics through Logic Switch Design
Chen, P., Alhussan, A., Cullis, P. R., & Cabral, H. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00159
Mengistu, G. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70511
Huang, Z., Yang, X., Wang, L., Huang, J., Zhou, Y., & Guo, X. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10844-x
Advancing mRNA therapeutics from design to delivery
Wang, Y., Kim, S., Qin, Z., Wang, Z., & Yoon, S. (2026) · Trends in biotechnology · doi:10.1016/j.tibtech.2026.09.005
Programmable mRNA vaccine materials for temporal control of antitumour immunity
Jeong, S. D., Tang, C., Wang, X., Szeglowski, A., Kim, Y., Kim, B., Sharma, P., Moon, J. J., Jiang, W., & Kim, B. Y. S. (2026) · Nature Reviews Materials · doi:10.1038/s41578-026-00974-8
- Authors
- Medjmedj, A., Genon, H., Hezili, D., Loth, A. N., Clemençon, R., Guimpied, C., Mollet, L., Bigot, A., Wien, F., Hamacek, J., Chapat, C., & Perche, F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Synchrotron SOLEIL (FR)
- Corresponding author
- Perche, Federico
- ORCID
- Venue
- Molecular Therapy Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2025-09
- Volume
- 36
- Issue
- 3
- Pages
- 102648
- ISSN
- 2162-2531 (ISSN-L)
- PMC
- PMC12355064
- OpenAlex
- W4412764102
- Cited by
- 19
- References
- 57
- Citations by year
- 2026: 18 · 2025: 1
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Therapy — Nucleic Acids (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-21-CE18-0037, 20231392)
- Conseil National de la Recherche Scientifique
- National Centre for Scientific Research
- National League Against Cancer
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- synthetic mRNA, mRNA 3' UTR, poly(A) tail, 5' untranslated region, mRNA half-life, luciferase reporter, SARS-CoV-2 spike protein, lipid nanoparticle mRNA vaccine, mRNA vaccine design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-05.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review